Fentora Patent Suit Just A Delay Tactic: Barr

Law360, New York (February 24, 2009, 12:00 AM EST) -- Barr Pharmaceuticals LLC has lodged counterclaims for declarations of noninfringement against Cephalon Inc. and Cima Labs Inc. over two patents related to the cancer painkiller Fentora, claiming that Cephalon and Cima sued Barr solely to trigger a 30-month stay on Barr's attempt to launch a generic version of the drug.

Barr filed the counterclaims Monday in the U.S. District Court for the District of Delaware, where two other lawsuits over the same Fentora patents are currently pending between the pharmaceutical companies.

Barr's counterclaims respond to Cephalon...
To view the full article, register now.